Carcinoma, Pancreatic Ductal: all 57 studies

Page 1 of 1. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.

• Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic AdenocarcinomaRecruitingNCT07259317Phase 2
• CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa)Not yet recruitingNCT07153289Phase 1/2
• Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic CancerRecruitingNCT06850623Phase 2
• Using Tumor Models to Determine TreatmentsRecruitingNCT06813079Phase 2
• Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPCNot yet recruitingNCT06573398Phase 2
• Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid TumorsRecruitingNCT06445062Phase 1/2
• Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid TumorsRecruitingNCT06128551Phase 1/2
• A Cohort Study on Screening and Follow-up of High-risk Population of PDAC Based on EUSNot yet recruitingNCT05621824
• Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASRecruitingNCT05379985Phase 1/2
• Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C MutationRecruitingNCT05288205Phase 1/2
• A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic AdenocarcinomaCompletedNCT02993731Phase 3Results posted
• A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal AdenocarcinomaTerminatedNCT02715804Phase 3Results posted
• An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI EndoscopyCompletedNCT02310230Not applicableResults posted
• Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic CancerTerminatedNCT02243007Phase 2Results posted
• PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic CancerCompletedNCT01839487Phase 2Results posted
• Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.CompletedNCT00471146Phase 3Results posted
• A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic MalignanciesTerminatedNCT06974734Phase 1
• A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.TerminatedNCT06704724Phase 1
• A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.Active, not recruitingNCT06447662Phase 1
• Selective Extended Dissection in Different Types of Pancreatic Head Cancer: A Retrospective Cohort Study.CompletedNCT05723978
• Predictive Factors for Resection and Survival in Type A Borderline Resectable Pancreatic Ductal Adenocarcinoma Patients After Neoadjuvant TherapyStatus unknownNCT05489458
• Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic SignaturesActive, not recruitingNCT05475366Not applicable
• Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid TumorsActive, not recruitingNCT05462717Phase 1
• Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)CompletedNCT05461430
• A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid TumorsCompletedNCT05293496Phase 1
• EUS Shear Wave for Solid Pancreatic Lesions.Status unknownNCT05095831
• Recurrence After Whipple's (RAW) StudyCompletedNCT04596865
• Ultrasound-enhanced Uptake of Chemotherapy in Patients With Inoperable Pancreatic Ductal AdenocarcinomaCompletedNCT04146441Phase 2
• A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in ChinaCompletedNCT04121286Phase 1
• A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid TumorsCompletedNCT04045496Phase 1
• A Registry Study of NanoKnife IRE for Stage 3 Pancreatic CancerActive, not recruitingNCT03899649
• A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic CancerActive, not recruitingNCT03899636Phase 3
• Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver MetastasesActive, not recruitingNCT03856658Phase 2
• Impact of Nationwide Enhanced Implementation of Best Practices in Pancreatic Cancer Care (PACAP-1)CompletedNCT03513705Not applicable
• Establishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT-I Study.Status unknownNCT03500068Not applicable
• Detection of MicroRNA-25 in the Diagnosis of Pancreatic CancerStatus unknownNCT03432624
• The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic CancerStatus unknownNCT03403101Phase 2
• Continuous Monitoring on the General WardCompletedNCT02933307Not applicable
• Standard Versus Extended Lymphadenectomy in Pancreatoduodenectomy for Patients With Pancreatic Head AdenocarcinomaStatus unknownNCT02928081Not applicable
• Correlation of Serum CA19-9 Levels With Levels in Saliva and Urine of Patients With Ductal Adenocarcinoma of the PancreasStatus unknownNCT02817308Not applicable
• Study of Changes and Characteristics of Genes in Patients With Pancreatic Cancer for Better Treatment SelectionCompletedNCT02750657
• Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid TumorsCompletedNCT02658214Phase 1
• Parvovirus H-1 (ParvOryx) in Patients With Metastatic Inoperable Pancreatic CancerCompletedNCT02653313Phase 1/2
• Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic CancerStatus unknownNCT02529579Phase 1/2
• Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes PatientsTerminatedNCT02456051
• According CTC to Compare the Influences of Different Methods to Remove the PDACStatus unknownNCT02451384Not applicable
• A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic CancerCompletedNCT02231723Phase 1
• Circulating Tumor Cells in Operative BloodCompletedNCT02150746
• Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02)CompletedNCT01808638Phase 1/2
• A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002CompletedNCT01608711Phase 2
• A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid TumorsCompletedNCT01478685Phase 1
• Amatuximab for High Mesothelin CancersTerminatedNCT01413451Early Phase 1
• Chemotherapy Selection Based on Therapeutic Targets for Advanced Pancreatic CancerStatus unknownNCT01394120Phase 2
• QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal CancerCompletedNCT01040000Phase 1/2
• A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic CancerCompletedNCT00902291Phase 2
• CT Pancreas PerfusionCompletedNCT00588367
• Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic CancerWithdrawnNCT00226746Phase 2

← Carcinoma, Pancreatic Ductal overview